John C. Byrd1, Richard R. Furman2, Steven Coutré3, Ian W. Flinn4, Jan A. Burger5, Kristie A. Blum1, Barbara Grant6, Jeff P. Sharman7, Morton Coleman2, William G. Wierda5, Jeffrey A. Jones1, Weiqiang Zhao8, Nyla A. Heerema8, Amy J. Johnson1, Juthamas Sukbuntherng9, Betty Chang9, Fong Clow9, Eric Hedrick9, Joseph J. Buggy9, Danelle F. James9, Susan O’Brien5
1Division of Hematology, Department of Internal Medicine
2Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York
3Division of Hematology and Stanford Cancer Center, Stanford University School of Medicine, Stanford
4Sarah Cannon Research Institute, Nashville
5Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston
6Vermont Cancer Center, University of Vermont, Burlington
7Willamette Valley Cancer Institute and Research Center and U.S. Oncology Research, Springfield, OR
8Department of Pathology, Ohio State University, Columbus
9Pharmacyclics, Sunnyvale